Autosomal dominant tubulointerstitial kidney disease (ADTKD)-uromodulin (UMOD) is the most common nonpolycystic genetic kidney disease, but it remains unrecognized due to its clinical heterogeneity and lack of screening test. Moreover, the fact that the clinical feature is a poor predictor of disease outcome further highlights the need for the development of mechanistic biomarkers in ADTKD. However, low abundant urinary proteins secreted by thick ascending limb cells, where UMOD is synthesized, have posed a challenge for the detection of biomarkers in ADTKD-UMOD. In the CRISPR/Cas9-generated murine model and patients with ADTKD-UMOD, we found that immunoglobulin heavy chain-binding protein (BiP), an endoplasmic reticulum chaperone, was exclusively upregulated by mutant UMOD in the thick ascending limb and easily detected by Western blot analysis in the urine at an early stage of disease. However, even the most sensitive ELISA failed to detect urinary BiP in affected individuals. We therefore developed an ultrasensitive, plasmon-enhanced fluorescence-linked immunosorbent assay (p-FLISA) to quantify urinary BiP concentration by harnessing the newly invented ultrabright fluorescent nanoconstruct, termed "plasmonic Fluor." p-FLISA demonstrated that urinary BiP excretion was significantly elevated in patients with ADTKD-UMOD compared with unaffected controls, which may have potential utility in risk stratification, disease activity monitoring, disease progression prediction, and guidance of endoplasmic reticulum-targeted therapies in ADTKD.NEW & NOTEWORTHY Autosomal dominant tubulointerstitial kidney disease (ADTKD)-uromodulin (UMOD) is an underdiagnosed cause of chronic kidney disease (CKD). Lack of ultrasensitive bioanalytical tools has hindered the discovery of low abundant urinary biomarkers in ADTKD. Here, we developed an ultrasensitive plasmon-enhanced fluorescence-linked immunosorbent assay (p-FLISA). p-FLISA demonstrated that secreted immunoglobulin heavy chain-binding protein is an early urinary endoplasmic reticulum stress biomarker in ADTKD-UMOD, which will be valuable in monitoring disease progression and the treatment response in ADTKD.

Department of Mechanical Engineering and Materials Science Institute of Materials Science and Engineering Washington University in St Louis St Louis Missouri

Division of Clinical and Translational Research Department of Anesthesiology Washington University in St Louis St Louis Missouri

Division of Nephrology Department of Internal Medicine Washington University School of Medicine St Louis Missouri

Pfizer Worldwide Research and Development Inflammation and Immunology Cambridge Massachusetts

Prime Medicine Incorporated Cambridge Massachusetts

Research Unit of Rare Diseases Department of Pediatric and Adolescent Medicine 1st Faculty of Medicine Charles University Prague Czech Republic

Section of Nephrology Wake Forest School of Medicine Winston Salem North Carolina

Siteman Cancer Center Washington University in St Louis St Louis Missouri

Zobrazit více v PubMed

Gast C, Marinaki A, Arenas-Hernandez M, Campbell S, Seaby EG, Pengelly RJ, Gale DP, Connor TM, Bunyan DJ, Hodanova K, Zivna M, Kmoch S, Ennis S, Venkat-Raman G. Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease. BMC Nephrol 19: 301, 2018. doi:10.1186/s12882-018-1107-y. PubMed DOI PMC

Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O; Kidney Disease: Improving Global Outcomes. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management-A KDIGO consensus report. Kidney Int 88: 676–683, 2015. doi:10.1038/ki.2015.28. PubMed DOI

Rampoldi L, Scolari F, Amoroso A, Ghiggeri G, Devuyst O. The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. Kidney Int 80: 338–347, 2011. doi:10.1038/ki.2011.134. PubMed DOI

Cybulsky AV. Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases. Nat Rev Nephrol 13: 681–696, 2017. doi:10.1038/nrneph.2017.129. PubMed DOI

Oslowski CM, Urano F. Measuring ER stress and the unfolded protein response using mammalian tissue culture system. Methods Enzymol 490: 71–92, 2011. doi:10.1016/B978-0-12-385114-7.00004-0. PubMed DOI PMC

Bernascone I, Janas S, Ikehata M, Trudu M, Corbelli A, Schaeffer C, Rastaldi MP, Devuyst O, Rampoldi L. A transgenic mouse model for uromodulin-associated kidney diseases shows specific tubulo-interstitial damage, urinary concentrating defect and renal failure. Hum Mol Genet 19: 2998–3010, 2010. doi:10.1093/hmg/ddq205. PubMed DOI

Bernascone I, Vavassori S, Di Pentima A, Santambrogio S, Lamorte G, Amoroso A, Scolari F, Ghiggeri GM, Casari G, Polishchuk R, Rampoldi L. Defective intracellular trafficking of uromodulin mutant isoforms. Traffic 7: 1567–1579, 2006. doi:10.1111/j.1600-0854.2006.00481.x. PubMed DOI

Kemter E, Prueckl P, Sklenak S, Rathkolb B, Habermann FA, Hans W, Gailus-Durner V, Fuchs H, de Angelis MH, Wolf E, Aigner B, Wanke R. Type of uromodulin mutation and allelic status influence onset and severity of uromodulin-associated kidney disease in mice. Hum Mol Genet 22: 4148–4163, 2013. doi:10.1093/hmg/ddt263. PubMed DOI

Rampoldi L, Caridi G, Santon D, Boaretto F, Bernascone I, Lamorte G, Tardanico R, Dagnino M, Colussi G, Scolari F, Ghiggeri GM, Amoroso A, Casari G. Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. Hum Mol Genet 12: 3369–3384, 2003. doi:10.1093/hmg/ddg353. PubMed DOI

Vylet'al P, Kublová M, Kalbáčová M, Hodaňová K, Barešová V, Stibůrková B, Sikora J, Hůlková H, Živný J, Majewski J, Simmonds A, Fryns J-P, Venkat-Raman G, Elleder M, Kmoch S. Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney Int 70: 1155–1169, 2006. doi:10.1038/sj.ki.5001728. PubMed DOI

Li M, Baumeister P, Roy B, Phan T, Foti D, Luo S, Lee AS. ATF6 as a transcription activator of the endoplasmic reticulum stress element: thapsigargin stress-induced changes and synergistic interactions with NF-Y and YY1. Mol Cell Biol 20: 5096–5106, 2000. doi:10.1128/MCB.20.14.5096-5106.2000. PubMed DOI PMC

Parker R, Phan T, Baumeister P, Roy B, Cheriyath V, Roy AL, Lee AS. Identification of TFII-I as the endoplasmic reticulum stress response element binding factor ERSF: its autoregulation by stress and interaction with ATF6. Mol Cell Biol 21: 3220–3233, 2001. doi:10.1128/MCB.21.9.3220-3233.2001. PubMed DOI PMC

Amin-Wetzel N, Saunders RA, Kamphuis MJ, Rato C, Preissler S, Harding HP, Ron D. A J-protein co-chaperone recruits BiP to monomerize IRE1 and repress the unfolded protein response. Cell 171: 1625–1637.e13, 2017. doi:10.1016/j.cell.2017.10.040. PubMed DOI PMC

Delpino A, Castelli M. The 78 kDa glucose-regulated protein (GRP78/BIP) is expressed on the cell membrane, is released into cell culture medium and is also present in human peripheral circulation. Biosci Rep 22: 407–420, 2002. doi:10.1023/a:1020966008615. PubMed DOI

Trychta KA, Back S, Henderson MJ, Harvey BK. KDEL receptors are differentially regulated to maintain the ER proteome under calcium deficiency. Cell Rep 25: 1829–1840.e26, 2018. doi:10.1016/j.celrep.2018.10.055. PubMed DOI PMC

Kern J, Untergasser G, Zenzmaier C, Sarg B, Gastl G, Gunsilius E, Steurer M. GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib. Blood 114: 3960–3967, 2009. doi:10.1182/blood-2009-03-209668. PubMed DOI

Panayi GS, Corrigall VM. Immunoglobulin heavy-chain-binding protein (BiP): a stress protein that has the potential to be a novel therapy for rheumatoid arthritis. Biochem Soc Trans 42: 1752–1755, 2014. doi:10.1042/BST20140230. PubMed DOI

Kim Y, Park SJ, Manson SR, Molina CA, Kidd K, Thiessen-Philbrook H, Perry RJ, Liapis H, Kmoch S, Parikh CR, Bleyer AJ, Chen YM. Elevated urinary CRELD2 is associated with endoplasmic reticulum stress-mediated kidney disease. JCI Insight 2: e92896, 2017. doi:10.1172/jci.insight.92896. PubMed DOI PMC

Luan J, Seth A, Gupta R, Wang Z, Rathi P, Cao S, Gholami Derami H, Tang R, Xu B, Achilefu S, Morrissey JJ, Singamaneni S. Ultrabright fluorescent nanoscale labels for the femtomolar detection of analytes with standard bioassays. Nat Biomed Eng 4: 518–530, 2020. doi:10.1038/s41551-020-0547-4. PubMed DOI PMC

Johnson BG, Dang LT, Marsh G, Roach AM, Levine ZG, Monti A, Reyon D, Feigenbaum L, Duffield JS. Uromodulin p.Cys147Trp mutation drives kidney disease by activating ER stress and apoptosis. J Clin Invest 127: 3954–3969, 2017. doi:10.1172/JCI93817. PubMed DOI PMC

Dihazi H, Dihazi GH, Bibi A, Eltoweissy M, Mueller CA, Asif AR, Rubel D, Vasko R, Mueller GA. Secretion of ERP57 is important for extracellular matrix accumulation and progression of renal fibrosis, and is an early sign of disease onset. J Cell Sci 126: 3649–3663, 2013. [Erratum in J Cell Sci 131: jcs219014, 2018]. doi:10.1242/jcs.125088. PubMed DOI

Kim Y, Lee H, Manson SR, Lindahl M, Evans B, Miner JH, Urano F, Chen YM. Mesencephalic astrocyte-derived neurotrophic factor as a urine biomarker for endoplasmic reticulum stress-related kidney diseases. J Am Soc Nephrol 27: 2974–2982, 2016. doi:10.1681/ASN.2014100986. PubMed DOI PMC

Tousson-Abouelazm N, Papillon J, Guillemette J, Cybulsky AV. Urinary ERdj3 and mesencephalic astrocyte-derived neutrophic factor identify endoplasmic reticulum stress in glomerular disease. Lab Invest 100: 945–958, 2020. doi:10.1038/s41374-020-0416-5. PubMed DOI

Dvela-Levitt M, Kost-Alimova M, Emani M, Kohnert E, Thompson R, Sidhom EH, et al. . Small molecule targets TMED9 and promotes lysosomal degradation to reverse proteinopathy. Cell 178: 521–535.e523, 2019. doi:10.1016/j.cell.2019.07.002. PubMed DOI

MANF stimulates autophagy and restores mitochondrial homeostasis to treat autosomal dominant tubulointerstitial kidney disease in mice